Berberine is not recognised as a functional ingredient in Korea. Glycemic functional claims are not permitted, and any wording equating it with or substituting it for medication (including GLP-1 agents) is prohibited. (Re-verify current status before publication.)

Marketed as a dietary supplement in the US; clinical commentary (e.g. UCLA Health) is explicit that it is not a substitute for GLP-1 medication.